 新闻中心产品分类 友情链接 |
|
![]()
Founded in 1997, Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech Co. Ltd are its major stock holders.
Located in Shangdong Mingshui Development Zone in China, its production site offers Recombinant Human Erythropoietin Injection(EPO)?Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)\Filgrastim?and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. Its workshop for genetically engineered drugs has area of 1,500 square meters, and workshop for micro-ecological drugs covers 2,000 square meters. Both workshops have passed China?s GMP certification. The company plans to construct new factory buildings to improve production capacity and meet increasing market demands.
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China?s biopharmaceutical industry after more than 10 years of development.
No.1 Chinese producer of Recombinant Human Erythropoietin Injection?CHO Cell?
One of leading bio-pharmaceutical suppliers in China
EPSINO is the first EPO Product put in Chinese market
The only EPO product free of human albumin in China
First-class G-CSF
Non-toxic certain bacteria combination
Diversity of target markets for treatment of renal disease, tumors, gastrointestinal tract disease
Advanced market- oriented R&D capabilities
Mature domestic marketing network
High-efficient international sales team
Improved market-oriented management team
Strict quality management system to ensure safety,effectiveness and stability |
| 公司名称： |
Shandong Kexing Bioproducts Co., Ltd |
公司类型： |
Manufacturer (制造商,贸易商) |
| 所 在 地： |
CN|中国/其它|Other |
公司规模： |
101 - 500 |
| 注册资本： |
未填写 |
注册年份： |
1997 |
| 资料认证： |
|
| 保 证 金： |
已缴纳 0.00 元 |
| 经营模式： |
制造商,贸易商 |
| 经营范围： |
Health & Medical Drugs |
| 主营行业： |
|
|
